A Missense Variant in PLP2 in Holstein Cattle with X-Linked Congenital Mast Cell Tumor.
bovine
cattle
congenital neoplasm
mast cell tumor
precision medicine
whole-genome sequencing
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
07 Sep 2022
07 Sep 2022
Historique:
received:
08
07
2022
revised:
28
08
2022
accepted:
05
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Congenital tumors occur infrequently in cattle. The aim of this study was to detail the clinicopathological phenotype of a Holstein calf with a congenital mast cell tumor and to identify the genetic cause by a whole-genome sequencing (WGS) trio-approach. An 18-day-old male Holstein calf was clinically examed and revealed multifocal, alopecic, thick and wrinkled skin lesions over the entire body. At 6 months of age, the general condition of the calf was characterized by retarded growth, poor nutritional status, and ulceration of the skin lesions. Histopathological examination revealed a primary cutaneous, poorly differentiated embryonal mast cell tumor with metastases in the lymph nodes and liver. Genetic analysis revealed a private X-linked variant in the PLP2 gene (chrX:87216480C > T; c.50C > T), which was present only in the genomes of the case (hemizygous) and his mother (heterozygous). It was absent in the sire as well as in 5365 control genomes. The identified missense variant exchanges the encoded amino acid of PLP2 at position 17 (p.Thr17Ile), which is classified as deleterious and affects a protein that plays a role in tumor growth and metastasis. Therefore, we suggested that the detected PLPL2 variant could be a plausible cause for this congenital condition in the affected calf.
Identifiants
pubmed: 36139188
pii: ani12182329
doi: 10.3390/ani12182329
pmc: PMC9494957
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Swiss National Science Foundation
ID : 172911
Pays : Switzerland
Références
Vet Dermatol. 2008 Jun;19(3):184-6
pubmed: 18477335
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Epigenet Insights. 2020 Oct 20;13:2516865720964802
pubmed: 33178991
Annu Rev Anim Biosci. 2019 Feb 15;7:89-102
pubmed: 30508490
Oncol Rep. 2010 Feb;23(2):371-6
pubmed: 20043097
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Front Immunol. 2017 Apr 12;8:424
pubmed: 28446910
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Neoplasia. 2006 Feb;8(2):104-11
pubmed: 16611403
Dtsch Tierarztl Wochenschr. 2006 Jan;113(1):32-5
pubmed: 16475553
Gigascience. 2020 Mar 1;9(3):
pubmed: 32191811
J Comp Pathol. 2021 Apr;184:84-94
pubmed: 33894884
Nat Immunol. 2011 Oct 19;12(11):1035-44
pubmed: 22012443
Cancer Res. 2017 Nov 1;77(21):e31-e34
pubmed: 29092934
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Immunol. 1991 Mar 1;146(5):1410-5
pubmed: 1704394
Vet Rec. 1999 Jul 17;145(3):81-2
pubmed: 10460031
J Histochem Cytochem. 2014 Oct;62(10):698-738
pubmed: 25062998
Vet Q. 2004 Dec;26(4):156-69
pubmed: 15663212
Anal Bioanal Chem. 2013 Feb;405(6):1893-901
pubmed: 22729357
Bioessays. 1989 Jun;10(6):193-6
pubmed: 2662964
Ann N Y Acad Sci. 2008 Nov;1143:83-104
pubmed: 19076346
Anim Genet. 2020 Jun;51(3):382-390
pubmed: 32069517
Science. 2009 Apr 24;324(5926):522-8
pubmed: 19390049
Can Vet J. 2001 Aug;42(8):635-7
pubmed: 11519274
Br J Cancer. 2012 Jan 17;106(2):307-13
pubmed: 22134506
PLoS Comput Biol. 2014 Jan;10(1):e1003440
pubmed: 24453961
Blood. 2017 Mar 16;129(11):1420-1427
pubmed: 28031180